The Effect of Royal Jelly on Growth and Short-Chain Fatty Acid Production of Probiotic Bacteria and Activity of Bacterial Procarcinogenic Enzymes in Rat Faeces

Polish Journal of Food and Nutrition Sciences

Volumn 62, Issue 4, 2012, Pages 251-258

  Haddadin, Malik S Y ^a   Haddadin, Jamal ^b   Benguiar, Rachida ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b MUTAH UNIVERSITY   (Jordan)

Author keywords

Faecal enzymes; Probiotic bacteria; Royal jelly; Short chain fatty acids

Indexed keywords

EID: 84867727700     PISSN: 12300322     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10222-012-0058-4     Document Type: Article

References (47)

1. Awaisheh S., In vitro studies of the effect of fermented dairy products containing probiotics and neutraceuticals on different characteristics of normal flora. Ph.D. 2003, Thesis, University of Jordan, Amman, Jordan.
2. Bernardeau M., Vernoux J.P., Henri-Dubernet S., Guéguen M., Safety assessment of dairy microorganisms: The Lactobacillus genus. Int. J. Food Microbiol., 2008, 126, SI, 278-285.
3. Bezkorovainy A., Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr., 2001, 73, S399-S405.
4. Bincoletto C., Eberlin S., Figueiredo C.A.V., Luengo M.B., Queiroz M.L., Effects produced by royal jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int. Immunopharmacol., 2005, 5, 679-688.
5. Burns A.J., Rowland I.R., Anti-carcinogenicity of probiotics and prebiotics. Curr. Issues Intest. Microbiol., 2000, 1, 13-24.
6. Djouzi Z., Andrieux C., Degivry M.-C., Bouley C., Szylit O., The association of yogurt starters with Lactobacillus casei DN 114.001 in fermented milk alters the composition and metabolism of intestinal microflora in germ-free rats and in human flora-associated rats. J. Nutr., 1997, 127, 2260-2266.
7. El-Nekeety, A.A., El-Kholy, W., Abbas, N.F., Ebaid, A., Amra, H.A., Abdel-Wahhab, M.A., Efficacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon, 2007, 50, 256-269.
8. Goldin B.R., Gorbach S.L., The effect of milk and lactobacilli feeding on human intestinal bacteria enzyme activity. Am. J. Clin. Nutr., 1984, 39, 756-761.
9. Guarner F., Malagelada J.R., Gut flora in health and disease. Lancet, 2003, 361, 512-519.
10. Haddadin M.S.Y., Nazer I., Sara' J.R., Robinson R.K., Effect of honey on the growth and metabolism of two bacterial species of intestinal origin. Pakistan J. Nutr., 2007, 6, 693-697.
11. Hinnebusch B.F., Meng S.F., Wu J.T., Archer S.Y., Hodin R.A., The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr., 2002, 132, 1012-1017.
12. Hyang M.A., Shin Y.P., Do K.L., Jung R.K., Min K.C., Si W.L., Hyung T.L., Kyung J.K., Nam J.H., Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis., 2011, 10, 116.
13. Inoue S., Koya-Miyata S., Ushio S., Iwaki K., Ikeda M., Kurimoto M., Royal jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Exp. Gerontol., 2003, 38, 965-969.
14. Kailasapathy K., Chin J., Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol., 2000, 78, 80-88.
15. Kamakura M., Mitani N., Fukuda T., Fukushima M., Antifatigue effect of fresh royal jelly in mice. J. Nutr. Sci. Vitaminol., 2001, 47, 394-401.
16. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., Kurimoto M., Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci. Biotechnol. Biochem., 2004, 68, 138-145.
17. Leblank A.D., Perdigon G., Reduction of β-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell, 2005, 29, 15-24.
18. Lichtenthaler R., Marx F., Total oxidant scavenging capacities of common European fruit and vegetable juices. J. Agric. Food Chem., 2005, 53, 103-110.
19. Liong M.T., Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in vivo evidence. Int. J. Mol. Sci., 2008, 9, 854-863.
20. Marsili R.T., Ostapenkoo H., Simmons R.E., Green D.E., High performance liquid chromatography determination of organic acids in dairy products. J. Food Sci., 1981, 46, 52-57.
21. Marteau P., Pochart P., Flourie B., Pellier P., Santos L., Desjeux J.F., Rambaud J.C., Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am. J. Clin. Nutr., 1990, 52, 685-688.
22. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., Matsumoto K., Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J. Nutr. Biochem., 2002, 13, 80-86.
23. Nagai T., Inoue R., Preparation and the functional properties of water extract and alkaline extract of royal jelly. Food Chem., 2004, 84, 181-186.
24. Nyman M., Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br. J. Nutr., 2002, 87, S163-S168.
25. Okamoto I., Taniguchi Y., Kunikita T., Kohno K., Iwaki K., Ikeda M., Kurimoto M., Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci., 2003, 73, 2029-2045.
26. Pan X.D., Chen F.Q., Wu T.X., Tang H.G., Zhao Z.Y., Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J. Zhejiang Univ. Sci. B, 2009a, 10, 258-263.
27. Pan X.D., Chen F.Q., Wu T.X., Tang H.G., Zhao Z.Y., The acid, bile tolerance and antimicrobial property of Lactobacillus acidophilus NIT. Food Contr., 2009b, 20, 598-602.
28. Perez-Conesa D., Lopez G., Ros G., Fermentation capabilities of bifidobacteria using nondigestible oligosaccharides, and their viability as probiotics in commercial powder infant formula. J. Food Sci., 2005, 70, M279-M285.
29. Pool-Zobel B.L., Neudecker C., Domizlaff I., Schillinger S., Ji U., Rumney C., Moretti M., Vilarini I., Scassellati-Sforzolini R., Rowland I., Lactobacillusand Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer, 1996, 26, 365-380.
30. Roberfroid M.B., Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr., 2000, 71, 1682-1687.
31. Roberfroid M.B., Prebiotics: preferential substrates for specific germs? Am. J. Clin. Nutr., 2001, 73, 407S-415S.
32. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., Matteuzzi D., Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol., 2005, 71, 6150-6158.
33. Saarela M., Mättö J., Mattila-Sandholm T., Safety aspects of Lactobacillus and Bifidobacterium species originating from human oro-gastrointestinal tract or from probiotic products. Microb. Ecol. Health Dis., 2002a, 14, 234-241.
34. Saarela M., Lahteenmaki L., Crittenden R., Salminen S., Mattila-Sandholm, T., Gut bacteria and health foods - the European perspective. Int. J. Food Microbiol., 2002b, 78, SI, 99-117.
35. Sanz M.L., Polemis N., Morales V., Coezo N., Drakoularakou A., Gibson G.R., Rastal R.A., In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J. Agric. Food Chem., 2005, 53, 2914-2921.
36. Sauerwald N., Polster J., Bengsch E., Niessen L., Vogel R.F., Combined antibacterial and antifungal properties of water-soluble fraction of royal jelly. Adv. Food Sci., 1998, 20, 46-52.
37. Saxelin M., Tynkkynen S., Mattila-Sandholm T., De Vos W.M., Probiotic and other functional microbes: from markets to mechanisms. Curr. Opin. Biotechnol., 2005, 16, 204-211.
38. Shanahan F., Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br. J. Nutr., 2002, 88 (Suppl. 1), S5-S9.
39. Stocker A., Schramel P., Kettrup A., Bengsch E., Trace and mineral elements in royal jelly and homeostatic effects. J. Trace Elem. Med. Biol., 2005, 19, 183-189.
40. Topping D.L., Short chain fatty acids produced by intestinal bacteria. Asia Pac. J. Clin. Nutr., 1996, 5, 15-19.
41. Upadhyay N., Moudgal V., Probiotics: A Review. JCOM, 2012, 19, 76-84.
42. Verschuren P.M., Functional foods: scientific and global perspectives. Br. J. Nutr., 2002, 88, S125-S130.
43. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., Yonekura M., Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium. Biotechnol. Tech., 1996, 10, 959-962.
44. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., Yonekura M., Stimulation of cell growth in the U-937 human myeloid cell line by honey royal jelly protein. Cytotechnology, 1998, 26, 23-27.
45. Wollowski I., Rechkemmer G., Pool-Zobel B.L., Protective role of probiotics and prebiotics in colon cancer Am. J. Clin. Nutr., 2001, 73(suppl), 451S-5S.
46. Yang X.Y., Yang D.S., Wei-Zhang, Wang J.M., Li C.Y, Hui Y, Lei K.F., Chen X.F., Shen N.H., Jin L.Q., Wang J.G., 10-Hydroxy-2-decenoic acid from Royal jelly: A potential medicine for RA. J. Ethnopharmacol., 2010, 128, 314-321.
47. th September 2012.